Carboplatin/Cisplatin
Sponsors
University Health Network, Toronto, Peking Union Medical College Hospital, Shanghai Hengrui Pharmaceutical Co., Ltd., Nanfang Hospital, Southern Medical University, HC Biopharma Inc.
Conditions
Advanced Solid TumorAdvanced Solid Tumor CancerBronchial NeoplasmsCarcinoma, BronchogenicLung DiseasesLung NeoplasmsNasopharyngeal CancerNeoplasms
Phase 1
Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models
NCT04646837
Start: 2021-05-01End: 2025-03-31Target: 20Updated: 2023-03-29
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
NCT05794477
Start: 2023-04-28End: 2025-12-31Target: 132Updated: 2023-06-02
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
RecruitingNCT07381829
Start: 2025-10-27End: 2026-12-30Target: 328Updated: 2026-02-02
Phase 2
A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer
CompletedNCT00603915
Start: 2006-06-30End: 2011-04-30Updated: 2019-02-28
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
RecruitingNCT06177925
Start: 2023-12-10End: 2026-09-30Target: 62Updated: 2023-12-20